These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 26402657)
1. The future of patient-derived tumor xenografts in cancer treatment. Sia D; Moeini A; Labgaa I; Villanueva A Pharmacogenomics; 2015; 16(14):1671-83. PubMed ID: 26402657 [TBL] [Abstract][Full Text] [Related]
2. Ovarian and cervical cancer patient derived xenografts: The past, present, and future. Boone JD; Dobbin ZC; Straughn JM; Buchsbaum DJ Gynecol Oncol; 2015 Aug; 138(2):486-91. PubMed ID: 26026736 [TBL] [Abstract][Full Text] [Related]
3. Molecular and clinical implementations of ovarian cancer mouse avatar models. Zayed AA; Mandrekar SJ; Haluska P Chin Clin Oncol; 2015 Sep; 4(3):30. PubMed ID: 26408297 [TBL] [Abstract][Full Text] [Related]
4. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization. Sun S; Zhang Z Front Med; 2016 Mar; 10(1):104-10. PubMed ID: 26926009 [TBL] [Abstract][Full Text] [Related]
5. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models. Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676 [TBL] [Abstract][Full Text] [Related]
6. Patient-derived xenografts: a valuable platform for clinical and preclinical research in pancreatic cancer. Wang Y; Cui J; Wang L Chin Clin Oncol; 2019 Apr; 8(2):17. PubMed ID: 30943729 [TBL] [Abstract][Full Text] [Related]
7. Of Mice and Melanoma: PDX System for Modeling Personalized Medicine. Hartsough EJ; Aplin AE Clin Cancer Res; 2016 Apr; 22(7):1550-2. PubMed ID: 26842234 [TBL] [Abstract][Full Text] [Related]
8. Patient-derived xenografts: A platform for accelerating translational research in prostate cancer. Davies AH; Wang Y; Zoubeidi A Mol Cell Endocrinol; 2018 Feb; 462(Pt A):17-24. PubMed ID: 28315377 [TBL] [Abstract][Full Text] [Related]
9. Patient-derived xenograft models of breast cancer and their predictive power. Whittle JR; Lewis MT; Lindeman GJ; Visvader JE Breast Cancer Res; 2015 Feb; 17(1):17. PubMed ID: 25849559 [TBL] [Abstract][Full Text] [Related]
10. Patient-derived xenograft (PDX) models, applications and challenges in cancer research. Abdolahi S; Ghazvinian Z; Muhammadnejad S; Saleh M; Asadzadeh Aghdaei H; Baghaei K J Transl Med; 2022 May; 20(1):206. PubMed ID: 35538576 [TBL] [Abstract][Full Text] [Related]
11. Establishment of patient-derived cancer xenografts in immunodeficient NOG mice. Chijiwa T; Kawai K; Noguchi A; Sato H; Hayashi A; Cho H; Shiozawa M; Kishida T; Morinaga S; Yokose T; Katayama M; Takenaka N; Suemizu H; Yamada R; Nakamura Y; Ohtsu T; Takano Y; Imai K; Miyagi Y; Nakamura M Int J Oncol; 2015 Jul; 47(1):61-70. PubMed ID: 25963555 [TBL] [Abstract][Full Text] [Related]
12. Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments. Zarzosa P; Navarro N; Giralt I; Molist C; Almazán-Moga A; Vidal I; Soriano A; Segura MF; Hladun R; Villanueva A; Gallego S; Roma J Clin Transl Oncol; 2017 Jan; 19(1):44-50. PubMed ID: 27718156 [TBL] [Abstract][Full Text] [Related]
14. Patient-Derived Xenograft: An Adjuvant Technology for the Treatment of Metastatic Disease. Bousquet G; Janin A Pathobiology; 2016; 83(4):170-6. PubMed ID: 27010922 [TBL] [Abstract][Full Text] [Related]
15. Choosing wisely - Preclinical test models in the era of precision medicine. Klinghammer K; Walther W; Hoffmann J Cancer Treat Rev; 2017 Apr; 55():36-45. PubMed ID: 28314175 [TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors. Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554 [TBL] [Abstract][Full Text] [Related]
17. Advances in patient-derived tumor xenografts: from target identification to predicting clinical response rates in oncology. Rosfjord E; Lucas J; Li G; Gerber HP Biochem Pharmacol; 2014 Sep; 91(2):135-43. PubMed ID: 24950467 [TBL] [Abstract][Full Text] [Related]
18. [Application and development of patient-derived tumor xenograft model in translational medicine of tumor]. Wang Z; Zhu Z Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):596-600. PubMed ID: 28534338 [TBL] [Abstract][Full Text] [Related]
19. Patient-derived xenograft models: an emerging platform for translational cancer research. Hidalgo M; Amant F; Biankin AV; Budinská E; Byrne AT; Caldas C; Clarke RB; de Jong S; Jonkers J; Mælandsmo GM; Roman-Roman S; Seoane J; Trusolino L; Villanueva A Cancer Discov; 2014 Sep; 4(9):998-1013. PubMed ID: 25185190 [TBL] [Abstract][Full Text] [Related]
20. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research. Jung J; Seol HS; Chang S Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]